RP Finger, C Issa… - Investigative Ophthalmology & Visual Science, 2009 - ARVO METHODS. In this prospective controlled cross-sectional observational study, 49
eyes of 26 patients with MacTel type 2 were investigated. Twenty-four eyes of 14
age-matched normal subjects served as the control. Reading acuity and ... Cited by 3 - Related articles - All 3 versions
JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ... Cited by 2 - Related articles - All 23 versions
FK Chen, PJ Patel, W Xing, C Bunce, C Egan, … - Investigative Ophthalmology & Visual Science, 2009 - ARVO METHODS. In this prospective study, 50 patients were enrolled with a range of
macular diseases. One examiner performed two consecutive microperimetry tests
for all patients using the same test strategy. Test–retest variability ... Related articles - All 5 versions
- ►duanessolution.com [PDF] PC Issa, FG Holz, HPN Scholl, G Bonn - Retina, 2009 - duanessolution.com 1. In 1968, Gass published a series of landmark articles describing fluorescein
angiography stud- ies of macular dysfunction secondary to retinal vascular
disease. One of these articles is referred to several times in the ... Related articles - View as HTML
D Karagiannis, I Georgalas, I Ladas, P … - Clinical Interventions in Aging, 2009 - pubmedcentral.nih.gov A 65-year-old lady presented with decreased vision in her left eye (LE). Best
corrected visual acuity (BCVA) was 1/20. Complete examination showed idiopathic
juxtafoveal retinal telangiectasis associated with subretinal ... Related articles - All 6 versions
- ►duanessolution.com JS Pulido, S Itty - British Journal of Ophthalmology, 2009 - bjo.bmj.com Initially, Rosenfeld and his coauthors used the standard dose of intravenous
bevacizumab that was used for colonic carcinoma. They treated a total of 18
patients in an open-labelled trial with infusions given every other week ... Related articles - All 5 versions
H Nomoto, F Shiraga, N Kuno, E Kimura, S … - Investigative Ophthalmology & Visual Science, 2009 - ARVO RESULTS. After intravitreal injection in the treated eye, the mean maximum
concentrations (C max ) of bevacizumab in the iris/ciliary body and
retina/choroid were 109,192.6, and 93,990.0 ng/g, respectively, whereas ... Related articles - All 3 versions